Related references
Note: Only part of the references are listed.Trends in serum cotinine concentrations among daily cigarette smokers: Data from NHANES 1999-2010
Ram B. Jain
SCIENCE OF THE TOTAL ENVIRONMENT (2014)
Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure
Gideon St Helen et al.
ADDICTION (2013)
Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation
Andy Z. X. Zhu et al.
CARCINOGENESIS (2013)
Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population
Mohammad Safiqul Islam et al.
CLINICA CHIMICA ACTA (2013)
A Nationwide Analysis of US Racial/Ethnic Disparities in Smoking Behaviors, Smoking Cessation, and Cessation-Related Factors
Dennis R. Trinidad et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2011)
A Sex-Specific Association between a 15q25 Variant and Upper Aerodigestive Tract Cancers
Dan Chen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
Catherine A. Wassenaar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Lung Cancer Risk Among Smokers of Menthol Cigarettes
William J. Blot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Racial Differences in the Relationship Between Number of Cigarettes Smoked and Nicotine and Carcinogen Exposure
Neal L. Benowitz et al.
NICOTINE & TOBACCO RESEARCH (2011)
Sex Differences in Lung Cancer Susceptibility: A Review
Chikako Kiyohara et al.
GENDER MEDICINE (2010)
Nicotinic Acetylcholine Receptor Region on Chromosome 15q25 and Lung Cancer Risk Among African Americans: A Case-Control Study
Christopher I. Amos et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Utility and Relationships of Biomarkers of Smoking in African-American Light Smokers
Man Ki Ho et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences
Maria N. Timofeeva et al.
CARCINOGENESIS (2009)
Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
M. K. Ho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6
Yuan Ming Di et al.
CURRENT DRUG METABOLISM (2009)
Fast model-based estimation of ancestry in unrelated individuals
David H. Alexander et al.
GENOME RESEARCH (2009)
Intermittent and light daily smoking across racial/ethnic groups in the United States
Dennis R. Trinidad et al.
NICOTINE & TOBACCO RESEARCH (2009)
Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression
Melissa Rotunno et al.
PLOS ONE (2009)
Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative
Geoffrey C. Kabat et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of black African descent
Jill C. Mwenifumbo et al.
HUMAN MUTATION (2008)
The CHRNA5-A3 Region on Chromosome 15q24-25.1 Is a Risk Factor Both for Nicotine Dependence and for Lung Cancer
Margaret R. Spitz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
CYP2A6 polymorphisms and risk for tobacco-related cancers
Ana Rossini et al.
PHARMACOGENOMICS (2008)
Comparison of aspects of smoking among the four histological types of lung cancer
S. A. Kenfield et al.
TOBACCO CONTROL (2008)
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine
Jill C. Mwenifiumbo et al.
PHARMACOGENOMICS (2007)
Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes
Federica Gemignani et al.
CARCINOGENESIS (2007)
The molecular epidemiology of lung cancer
Ann G. Schwartz et al.
CARCINOGENESIS (2007)
The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: Sex-specific association with urinary 4-(methyinitrosamino)-1-(3-pyridyl)-1-butanol glucuroniclation phenotype and risk for lung cancer
Carla J. Gallagher et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke
Assieh A. Melikian et al.
NICOTINE & TOBACCO RESEARCH (2007)
Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States)
Paul F. Pinsky
CANCER CAUSES & CONTROL (2006)
Ethnic and racial differences in the smoking-related risk of lung cancer
CA Haiman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism
JE Larsen et al.
CANCER CAUSES & CONTROL (2005)
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers
M Fujieda et al.
CARCINOGENESIS (2004)
The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo
EM Sellers et al.
NICOTINE & TOBACCO RESEARCH (2003)